These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38402943)

  • 1. Efficacy of a novel dentifrice containing bioactive glass-ceramic for dentinal hypersensitivity: A double-blind randomized controlled trial in Chinese adults.
    Li J; Han Q; Zhang L; Zhang J; Yin W; Zhong Y
    J Dent; 2024 May; 144():104898. PubMed ID: 38402943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a novel bioactive glass-ceramic on dentinal tubule occlusion: an in vitro study.
    Zhong Y; Liu J; Li X; Yin W; He T; Hu D; Liao Y; Yao X; Wang Y
    Aust Dent J; 2015 Mar; 60(1):96-103. PubMed ID: 25329231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the efficacy in providing instant relief of dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride relative to a benchmark desensitizing toothpaste containing 2% potassium ion and 1450 ppm fluoride, and to a control toothpaste with 1450 ppm fluoride: a three-day clinical study in New Jersey, USA.
    Nathoo S; Delgado E; Zhang YP; DeVizio W; Cummins D; Mateo LR
    J Clin Dent; 2009; 20(4):123-30. PubMed ID: 19831165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy of a 5% calcium sodium phosphosilicate (Novamin) containing dentifrice for the relief of dentinal hypersensitivity: a clinical study.
    Rajesh KS; Hedge S; Arun Kumar MS; Shetty DG
    Indian J Dent Res; 2012; 23(3):363-7. PubMed ID: 23059574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the clinical efficacy of a new dentifrice containing 8.0% arginine, calcium carbonate, and 1000 ppm fluoride to a commercially available sensitive toothpaste containing 2% potassium ion on dentin hypersensitivity: a randomized clinical trial.
    Kakar A; Kakar K; Sreenivasan PK; DeVizio W; Kohli R
    J Clin Dent; 2012; 23(2):40-7. PubMed ID: 22779216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of an Experimental Occlusion Technology Toothpaste in the Relief of Dentinal Hypersensitivity: An 8-week Randomised Controlled Trial.
    Creeth JE; Burnett GR
    Oral Health Prev Dent; 2021 Mar; 19():195-202. PubMed ID: 33723979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the efficacy in providing instant relief of dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride to a benchmark desensitizing toothpaste containing 2% potassium ion and 1450 ppm fluoride, and to a control toothpaste with 1450 ppm fluoride: a three-day clinical study in Mississauga, Canada.
    Ayad F; Ayad N; Delgado E; Zhang YP; DeVizio W; Cummins D; Mateo LR
    J Clin Dent; 2009; 20(4):115-22. PubMed ID: 19831164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of instant desensitization after a single topical application over 30 days: a randomized trial.
    Samuel SR; Khatri SG; Acharya S; Patil ST
    Aust Dent J; 2015 Sep; 60(3):336-42. PubMed ID: 26211687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative clinical study investigating the efficacy of a test dentifrice containing 8% strontium acetate and 1040 ppm sodium fluoride versus a marketed control dentifrice containing 8% arginine, calcium carbonate, and 1450 ppm sodium monofluorophosphate in reducing dentinal hypersensitivity.
    Hughes N; Mason S; Jeffery P; Welton H; Tobin M; O'Shea C; Browne M
    J Clin Dent; 2010; 21(2):49-55. PubMed ID: 20669816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the clinical efficacy in reducing dentin hypersensitivity of a new dentifrice containing 8.0% arginine, calcium carbonate, and 1000 ppm sodium monofluorophosphate to a commercially available toothpaste containing 1000 ppm sodium monofluorophosphate: an eight-week clinical trial on adults in New Delhi, India.
    Kakar A; Kakar K; Sreenivasan PK; DeVizio W; Kohli R
    J Clin Dent; 2012; 23(2):33-9. PubMed ID: 22779215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical efficacy of three toothpastes in reducing dentin hypersensitivity.
    Li Y; Lee S; Zhang YP; Delgado E; DeVizio W; Mateo LR
    J Clin Dent; 2011; 22(4):113-20. PubMed ID: 22403987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of two treatment regimens combining in-office and at-home programs for dentin hypersensitivity relief: a 24-week clinical study.
    Hamlin D; Mateo LR; Dibart S; Delgado E; Zhang YP; DeVizio W
    Am J Dent; 2012 Jun; 25(3):146-52. PubMed ID: 22988684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An exploratory clinical trial to evaluate the efficacy of an experimental dentifrice formulation in the relief of dentine hypersensitivity.
    Parkinson C; Constantin P; Goyal C; Hall C
    J Dent; 2017 Jan; 56():39-44. PubMed ID: 27777061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy in reducing dentin hypersensitivity of a dentifrice containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride compared to a dentifrice containing 8% strontium acetate and 1040 ppm fluoride under consumer usage conditions before and after switch-over.
    Schiff T; Mateo LR; Delgado E; Cummins D; Zhang YP; DeVizio W
    J Clin Dent; 2011; 22(4):128-38. PubMed ID: 22403989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of a calcium sodium phosphosilicate desensitizer in reducing cervical dentin hypersensitivity: a pilot study.
    Narongdej T; Sakoolnamarka R; Boonroung T
    J Am Dent Assoc; 2010 Aug; 141(8):995-9. PubMed ID: 20675425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a toothpaste containing 8% arginine and calcium carbonate for immediate and lasting relief of dentin hypersensitivity: A simple and effective in-office procedure.
    Ayad F; Ayad N; Vazquez J; Zhang YP; Mateo LR; Cummins D
    Am J Dent; 2018 Jun; 31(3):135-140. PubMed ID: 30028931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of hypersensitivity reduction of a dentifrice containing 0.3% triclosan, 2.0% PVM/MA copolymer, 0.243% NaF and specially-designed silica as compared to a dentifrice containing 0.454% stannous fluoride, sodium hexametaphosphate and zinc lactate and to a dentifrice containing 0.243% NaF on dentin hypersensitivity reduction: an 8-week study.
    Chaknis P; Panagakos FS; DeVizio W; Sowinski J; Petrone D; Proskin H
    Am J Dent; 2011 Jul; 24 Spec No A():14A-20A. PubMed ID: 22216653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled clinical trial to assess the desensitizing effect of a stannous fluoride dentifrice.
    He T; Barker ML; Biesbrock A; Sharma N
    Am J Dent; 2014 Apr; 27(2):106-10. PubMed ID: 25000669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical study to assess the effect of a stabilized stannous fluoride dentifrice on hypersensitivity relative to a marketed sodium fluoride/triclosan control.
    He T; Barker ML; Biesbrock AR; Miner M; Qaqish J; Sharma N
    J Clin Dent; 2014; 25(2):13-8. PubMed ID: 25122977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of theobromine-containing toothpaste on dentin tubule occlusion in situ.
    Amaechi BT; Mathews SM; Mensinkai PK
    Clin Oral Investig; 2015 Jan; 19(1):109-16. PubMed ID: 24671714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.